您的位置: 首页 > 农业专利 > 详情页

antigen binding protein, transfected or transfected recombinant host cell, pharmaceutical composition, method for treating a human patient afflicted with immune mediated inflammation, and use of an antigen binding protein
专利权人:
Glaxo Group Limited
发明人:
Alan Peter Lewis,Gary Peter Bembridge,George Kopsidas,Jane Elizabeth Clarkson,Jonathan Henry Ellis,Paul Andrew Hamblin,Ruth McAdam
申请号:
BRPI0818620
公开号:
BRPI0818620A2
申请日:
2008.10.03
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
The present invention relates to antigen binding proteins to human IL-23, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as Rheumatoid Arthritis (RA).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充